AUSTRALIA-WIDE LOW FLAT RATE $9.90

Close Notification

Your cart does not contain any items

$296.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Wiley-Blackwell
27 May 2021
Aortic Valve Transcatheter Intervention Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over.

Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices.

This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.
Edited by:   , , , , , , , , ,
Imprint:   Wiley-Blackwell
Country of Publication:   United Kingdom
Dimensions:   Height: 257mm,  Width: 185mm,  Spine: 20mm
Weight:   771g
ISBN:   9781119720591
ISBN 10:   1119720591
Pages:   288
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

About the Editors Marco Zimarino, Institute of Cardiology “G. d’Annunzio” University, Interventional Cath Lab, ASL 2 Abruzzo, Chieti, Italy Ron Waksman, MedStar Heart & Vascular Institute, Medstar Washington Hospital Center, Washington, DC, USA Ignacio J. Amat-Santos, Department of Cardiology, Instituto de Ciencias del Corazón, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Hospital Clínico Universitario de Valladolid, Spain Corrado Tamburino, Azienda Ospedaliero-Universitaria Policlinico “G. Rodolico- San Marco”, University of Catania, Catania, Italy

See Also